We are live on
!
Find out more
IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
36 hedge funds and large institutions have $4.66M invested in ImmunoCellular Therapeutics, Ltd. in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
34% more capital invested
Capital invested by funds: $3.49M → $4.66M (+$1.17M)
4% more call options, than puts
Call options by funds: $705K | Put options by funds: $678K
8% less funds holding
Funds holding: 39 → 36 (-3)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
11
Closed
9
Calls
$705K
Puts
$678K
Net Calls
+$27K
Net Calls Change
+$176K
Top Buyers
Top Sellers
| 1 |
Group One Trading
Chicago,
Illinois
|
-$196K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$136K |
| 3 |
OC
Oppenheimer & Co
New York
|
-$119K |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
-$111K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$86.9K |
